Search

everythinglearnresearchcommunity

for

Search:↓

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

Hair and nails are similar keratin structures with different shapes and growth, affected by the same diseases and environmental factors.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

A new 3D culture system helps grow and study mouse skin stem cells for a long time.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Women with PCOS are at higher risk for gum disease, and managing shared risk factors can help both conditions.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Dermatopathology has made significant progress but many skin diseases remain incurable, requiring ongoing research.

miRNA-based therapies show promise for treating skin diseases, including hair loss, in animals.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

Stem cell research and regenerative medicine have made significant advancements in treating various diseases and conditions.

Genes play a significant role in male-pattern baldness, and understanding them could lead to new treatments and insights into related health issues.

Deep learning helps detect skin conditions and is advancing dermatology diagnosis and treatment.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Inducing ferroptosis in hepatic stellate cells is crucial for treating liver fibrosis.

The document concludes that while there are promising methods to control CRISPR/Cas9 gene editing, more research is needed to overcome challenges related to safety and effectiveness for clinical use.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

The lecture concluded that drugs for human enhancement are here to stay and called for their responsible development and fair access.

Dogs with dermatomyositis, especially Collies and Shetland Sheepdogs, need better treatments for their skin and muscle inflammation.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Corticosteroids are the most effective treatment for Satoyoshi syndrome.

RSPO1 mutations in certain patients lead to skin cells that don't develop properly and are more likely to become invasive, increasing the risk of skin cancer.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

Damaged hair follicles make mice more prone to skin inflammation and skin cancer after UV exposure.

Researchers created human hair follicles using a new method that could help treat hair loss.

Post-finasteride syndrome causes sexual, physical, and psychological symptoms, but more research is needed to understand its causes and connection to finasteride.

Hair health depends on various factors and hair loss can significantly affect a person's well-being; understanding hair biology is key for creating effective hair care treatments.